Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Sarcoma 3

Conditions

Sarcoma 959Glioblastoma 299Gliosarcoma 288Osteosarcoma 285Brain Neoplasms 195Dendritic Cell Sarcoma, Interdigitating 188Gastrointestinal Stromal Tumors 180Bone Neoplasms 172Lymphoma 160Central Nervous System Neoplasms 160Astrocytoma 155Sarcoma, Ewing 150Glioma 148Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Lymphoma, Non-Hodgkin 143Burkitt Lymphoma 139Neoplasms 137Recurrence 134Lymphoma, Large B-Cell, Diffuse 128Lymphoma, Follicular 128Neuroblastoma 126Rhabdomyosarcoma 125Hodgkin Disease 124Oligodendroglioma 123Breast Neoplasms 123Lymphoma, Mantle-Cell 117Leukemia, Myeloid, Acute 117Leukemia, Lymphocytic, Chronic, B-Cell 117Lymphoma, B-Cell, Marginal Zone 113Leukemia 111

Interventions

Hydroxyurea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Fibroma × Sarcoma × Clear all
NCT04281381 2026-05-15

Observing People With Desmoid-Type Fibromatosis

Memorial Sloan Kettering Cancer Center

Recruiting
100 enrolled
Sarcoma

Fibroma, Desmoid Tumors

NCT06113094 2023-11-02

CARDT

University Hospital, Strasbourg, France

Unknown
30 enrolled
Sarcoma

Fibroma, Desmoid Tumors

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn
Sarcoma

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡